Wibke Gesine Janzarik

Wibke Gesine Janzarik

Auto-generated profile, based on publicly available information

Wibke Gesine Janzarik

Department of Neuropediatrics and Muscle Disorders, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2012 in Developmental Medicine & Child Neurology
Verified
Journal Article
Open access
PDF file
NJNikolai Jung
Nikolai Jung
WJWibke G Janzarik
Wibke G Janzarik
IDIgor Delvendahl
Igor Delvendahl
AMAlexander Münchau
Alexander Münchau
MBMonica Biscaldi
Monica Biscaldi
VMVolker Mall
Volker Mall
Aim  We aimed to investigate the induction of long‐term potentiation (LTP)‐like plasticity by paired associative stimulation (PAS) in patients with high‐functioning autism and Asperger syndrome (HFA/AS).Method  PAS with an interstimulus interval between electrical and transcranial magnetic stimulation of 25 ms (PAS25) was performed in patients with HFA/AS (n=9; eight males, one female; mean age 17y 11mo, SD 4y 5mo) and in typically developing age‐matched volunteers (n=9; five males, four females; mean age 22y 4mo, SD 5y 2mo). The amplitude of motor‐evoked potentials was measured before PAS25, immediately after stimulation, and 30 minutes and 60 minutes later. A PAS protocol adapted to individual N20 latency (PASN20+2) was performed in six additional patients with HFA/AS. Short‐interval intracortical inhibition was measured using paired‐pulse stimulation.Results  In contrast to the typically developing participants, the patients with HFA/AS did not show a significant increase in motor‐evoked potentials after PAS25. This finding could also be demonstrated after adaptation for N20 latency. Short‐interval intracortical inhibition of patients with HFA/AS was normal compared with the comparison group and did not correlate with PAS effect.Interpretation  Our results show a significant impairment of LTP‐like plasticity induced by PAS in individuals with HFA/AS compared with typically developing participants. This finding is in accordance with results from animal studies as well as human studies. Impaired LTP‐like plasticity in patients with HFA/AS points towards reduced excitatory synaptic connectivity and deficits in sensory‐motor integration in these patients.

28 October 2020 in Biomedicines
Verified
Journal Article
Open access
PDF file
JDJan Henje Döring
Jan Henje Döring
ASAfshin Saffari
Afshin Saffari
TBThomas Bast
Thomas Bast
KBKnut Brockmann
Knut Brockmann
LELaura Ehrhardt
Laura Ehrhardt
SSSteffen Syrbe
Steffen Syrbe
Pathogenic variants in PRRT2, encoding the proline-rich transmembrane protein 2, have been associated with an evolving spectrum of paroxysmal neurologic disorders. Based on a cohort of children with PRRT2-related infantile epilepsy, this study aimed at delineating the broad clinical spectrum of PRRT2-associated phenotypes in these children and their relatives. Only a few recent larger cohort studies are on record and findings from single reports were not confirmed so far. We collected detailed genetic and phenotypic data of 40 previously unreported patients from 36 families. All patients had benign infantile epilepsy and harbored pathogenic variants in PRRT2 (core cohort). Clinical data of 62 family members were included, comprising a cohort of 102 individuals (extended cohort) with PRRT2-associated neurological disease. Additional phenotypes in the cohort of patients with benign sporadic and familial infantile epilepsy consist of movement disorders with paroxysmal kinesigenic dyskinesia in six patients, infantile-onset movement disorders in 2 of 40 individuals, and episodic ataxia after mild head trauma in one girl with bi-allelic variants in PRRT2. The same girl displayed a focal cortical dysplasia upon brain imaging. Familial hemiplegic migraine and migraine with aura were reported in nine families. A single individual developed epilepsy with continuous spikes and waves during sleep. In addition to known variants, we report the novel variant c.843G>T, p.(Trp281Cys) that co-segregated with benign infantile epilepsy and migraine in one family. Our study highlights the variability of clinical presentations of patients harboring pathogenic PRRT2 variants and expands the associated phenotypic spectrum.

1 September 2021 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
IDIvana Dzinovic
Ivana Dzinovic
MŠMatej Škorvánek
Matej Škorvánek
JNJán Necpál
Ján Necpál
SBSylvia Boesch
Sylvia Boesch
JŠJana Švantnerová
Jana Švantnerová
MZMichael Zech
Michael Zech

1 July 2019 in Pregnancy Hypertension
Verified
Journal Article
Closed access
WJWibke G. Janzarik
Wibke G. Janzarik
JJJenny Jacob
Jenny Jacob
EKEvi Katagis
Evi Katagis
FMFiliz Markfeld-Erol
Filiz Markfeld-Erol
LSLinda Sommerlade
Linda Sommerlade
MRMatthias Reinhard
Matthias Reinhard

5 May 2021 in Movement Disorders
Verified
Journal Article
Open access
PDF file
MZMichael Zech
Michael Zech
RJRobert Jech
Robert Jech
SBSylvia Boesch
Sylvia Boesch
MŠMatej Škorvánek
Matej Škorvánek
JNJán Necpál
Ján Necpál
KOKonrad Oexle
Konrad Oexle
Background: Despite the established value of genomic testing strategies, practice guidelines for their use do not exist in many indications.Objectives: We sought to validate a recently introduced scoring algorithm for dystonia, predicting the diagnostic utility of whole‐exome sequencing (WES) based on individual phenotypic aspects (age‐at‐onset, body distribution, presenting comorbidity).Methods: We prospectively enrolled a set of 209 dystonia‐affected families and obtained summary scores (0–5 points) according to the algorithm. Singleton (N = 146), duo (N = 11), and trio (N = 52) WES data were generated to identify genetic diagnoses.Results: Diagnostic yield was highest (51%) among individuals with a summary score of 5, corresponding to a manifestation of early‐onset segmental or generalized dystonia with coexisting non‐movement disorder‐related neurological symptoms. Sensitivity and specificity at the previously suggested threshold for implementation of WES (3 points) was 96% and 52%, with area under the curve of 0.81.Conclusions: The algorithm is a useful predictive tool and could be integrated into dystonia routine diagnostic protocols. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson Movement Disorder Society

1 July 2024 in Disease Models & Mechanisms
Verified
Journal Article
Open access
TKTheresa Kagermeier
Theresa Kagermeier
SHStefan Hauser
Stefan Hauser
KSKseniia Sarieva
Kseniia Sarieva
LLLucia Laugwitz
Lucia Laugwitz
SGSamuel Groeschel
Samuel Groeschel
SMSimone Mayer
Simone Mayer
Pontocerebellar hypoplasia type 2a (PCH2a) is an ultra-rare, autosomal recessive pediatric disorder with limited treatment options. Its anatomical hallmark is hypoplasia of the cerebellum and pons accompanied by progressive microcephaly. A homozygous founder variant in TSEN54, which encodes a tRNA splicing endonuclease (TSEN) complex subunit, is causal. The pathological mechanism of PCH2a remains unknown due to the lack of a model system. Therefore, we developed human models of PCH2a using regionalized neural organoids. We generated induced pluripotent stem cell (iPSC) lines from three males with genetically confirmed PCH2a and subsequently differentiated cerebellar and neocortical organoids. Mirroring clinical neuroimaging findings, PCH2a cerebellar organoids were reduced in size compared to controls starting early in differentiation. Neocortical PCH2a organoids demonstrated milder growth deficits. Although PCH2a cerebellar organoids did not upregulate apoptosis, their stem cell zones showed altered proliferation kinetics, with increased proliferation at day 30 and reduced proliferation at day 50 compared to controls. In summary, we generated a human model of PCH2a, providing the foundation for deciphering brain region-specific disease mechanisms. Our first analyses suggest a neurodevelopmental aspect of PCH2a.